Quick Takeaways
- Darwin Global Management, Ltd. filed SCHEDULE 13G/A for BELITE BIO, INC Ordinary Shares, par value US$0.0001 per share (BLTE).
- Disclosed ownership: 8.1%.
- Date of event: 31 Dec 2025.
Darwin Global Management, Ltd. - 31 Dec 2025 SCHEDULE 13G/A Report for BELITE BIO, INC Ordinary Shares, par value US$0.0001 per share (BLTE)
- Filing Manager
- Darwin Global Management, Ltd.
- Reporting Manager
- Darwin Global Management, Ltd.
- Symbol
- BLTE
- Shares outstanding
- 37,379,062 shares
- Disclosed Ownership
- 3,027,704 shares
- Ownership
- 8.1%
- Form type
- SCHEDULE 13G/A
- Filing time
- 17 Feb 2026, 16:30:28 UTC
- Date of event
- 31 Dec 2025
- Previous filing
- 10 Dec 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Darwin Global Management, Ltd. disclosed 8.1% ownership in BELITE BIO, INC Ordinary Shares, par value US$0.0001 per share (BLTE) on 31 Dec 2025."
What Changed
- Previous schedule filing date: 10 Dec 2025.
- Current filing was accepted on 17 Feb 2026, 16:30.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (3)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Darwin Global Management, Ltd. | 8.1% | 3,027,704 | 0 | 3,027,704 | /s/ John Legge | John Legge, Director and Chief Financial Officer | |
| Trehan Abhishek | 8.1% | 3,027,704 | 0 | 3,027,704 | /s/ Dr. Abhishek Trehan | Dr. Abhishek Trehan, individually | |
| Darwin Global Master Fund, Ltd. | 7.8% | 2,928,575 | 0 | 2,928,575 | /s/ John Legge | By: Darwin Global Management, Ltd, its Investment Manager, By: John Legge, Director and Chief Financial Officer |